Pharmaceutical company owner arrested after children's deaths from cough syrup
The police of Madhya Pradesh state arrested the owner of Sresan Pharma, which produced the cough syrup Coldrif, responsible for the deaths of at least 20 children. An inspection revealed that the syrup contained the toxic component diethylene glycol in excessive quantities.
During the inspection at the Sresan Pharma facility, it was found that samples of the syrup contained the toxic component diethylene glycol, which is used in the manufacturing of resins, paints, lacquers, inks, and adhesives. It was established that the company added 46-48% of the poison instead of the permissible limit of 0.1%. Unregistered containers of diethylene glycol were found in the factory premises.
After the arrest, charges against the owner of Sresan Pharma include gross violations of manufacturing practices and non-compliance with raw material and components inspection standards. The operations of the pharmaceutical company in Tamil Nadu have been halted, and the company has been stripped of its license. The Coldrif syrup has been banned for sale in nine states of India.
Investigation into cough syrup manufacturer due to toxic diethylene glycol content
Earlier, information emerged that more than 10 children in India died after consuming the cough syrup. A large amount of toxic diethylene glycol was found in this medication. The Food and Drug Administration recommended revoking the pharmaceutical company’s license.
Incidentally, flights between India and China have been announced to resume after a five-year break.
After the deaths of children due to cough syrup, the pharmaceutical company in India was stripped of its license, and sales of this medication were banned in nine states. Charges against the company owner include gross violations of manufacturing standards. The investigation revealed that the syrup contained toxic diethylene glycol in excessive quantities.